0001731122-24-000375.txt : 20240307
0001731122-24-000375.hdr.sgml : 20240307
20240307173037
ACCESSION NUMBER: 0001731122-24-000375
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240226
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paglia John Kenneth
CENTRAL INDEX KEY: 0001627832
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40471
FILM NUMBER: 24731440
MAIL ADDRESS:
STREET 1: 746 GRABLE PLACE
CITY: NEWBURY PARK
STATE: CA
ZIP: 91320
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPLASH BEVERAGE GROUP, INC.
CENTRAL INDEX KEY: 0001553788
STANDARD INDUSTRIAL CLASSIFICATION: BEVERAGES [2080]
ORGANIZATION NAME: 04 Manufacturing
IRS NUMBER: 341720075
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1314 E LAS OLAS BLVD, SUITE 221
CITY: FORT LAUDERDALE
STATE: FL
ZIP: 33301
BUSINESS PHONE: 954.745.5815
MAIL ADDRESS:
STREET 1: 1314 E LAS OLAS BLVD, SUITE 221
CITY: FORT LAUDERDALE
STATE: FL
ZIP: 33301
FORMER COMPANY:
FORMER CONFORMED NAME: Canfield Medical Supply, Inc.
DATE OF NAME CHANGE: 20120709
4
1
ownership.xml
X0508
4
2024-02-26
0
0001553788
SPLASH BEVERAGE GROUP, INC.
SBEV
0001627832
Paglia John Kenneth
C/O SPLASH BEVERAGE GROUP, INC.
1314 E LAS OLAS BLVD, SUITE 221
FORT LAUDERDALE
FL
33301
1
0
0
0
0
Stock options
0.5275
2024-02-26
4
A
0
600000
0.00
A
2034-02-26
Common stock
600000
600000
D
The options were issued in connection with serving as a director on SBEV's board, pursuant to the 2020 Long-Term Incentive Compensation Plan. The options are subject to the following vesting schedule: (i) 200,000 shares vested upon execution of Dr. Paglia's offer letter, and (ii) the remaining 400,000 shares vesting 50,000 per quarter beginning May 23, 2024, and ending February 25, 2026. Should there be a change in control of the Company, the options will all immediately vest.
Dr. Paglia's shares remain subject to termination in the event Dr. Paglia chooses to resign during the first 90 days of his tenure.
The expiration date of the options is fixed at 2/26/2034 and is unaffected whether or not Dr. Paglia is engaged with the Company.
/s/ John Paglia
2024-03-07